Vertex Pharmaceuticals

Vertex Pharmaceuticals is a biotechnology company founded in 1989, headquartered in Boston, Massachusetts. The company focuses on transforming the treatment of serious diseases through innovative drug design. It is known for its unique approach to rational drug design, which sets it apart from traditional combinatorial chemistry methods. Vertex has developed a range of treatments, particularly for cystic fibrosis and other rare genetic disorders. Key products include Kalydeco, Orkambi, Symdeko, and Trikafta, all aimed at improving the lives of patients with specific genetic mutations. The company also engages in collaborations, such as its partnership with CRISPR Therapeutics, to explore new therapies for conditions like Duchenne muscular dystrophy. With a strong emphasis on scientific innovation, Vertex continues to invest in research and development, positioning itself as a leader in the biotechnology sector.

Research Boston, United States Founded 1989 ~5,647 employees NASDAQ: VRTX

Work at Vertex Pharmaceuticals in HR or recruiting? Claim this page

Employees
5,647
+1.5% in the 3 months to Jun 2025
Revenue / employee
$2M
Revenue ~$11.1B
Stock
VRTX
NASDAQ
12-month attrition
7.7%
Tech: 10.1%
H1B filings, FY2026
108
Sponsors visas
Open jobs
186
Last 30 days

Headcount trend

Vertex Pharmaceuticals went from 4,638 employees in Jul 2023 to 5,647 in Jun 2025. Jan to Jun 2025: 361 people joined, 142 left.

Headcount data through Jun 2025

Org structure

Headcount by department

Other3,964
Operations611
Engineering470
Sales155
Marketing143
Success110
Finance106
HR82

Executive compensation

Hiring now

See all jobs

Salaries at Vertex Pharmaceuticals

All salaries

38 salary profiles in the US

Most reported roles

Pay by level, gender and ethnicity

H-1B sponsorship

H-1B Sponsorship Moderate
H-1B Filings by Department
Engineering342
Operations47
Consulting35
Finance8
Executive8

The department split adds up all the years listed above. FY2026 alone: 108 filings.

Peer reviews

Worked with someone at Vertex Pharmaceuticals?

Anonymous peer reviews on OffTheRecord

Read or write a review

Similar companies

Vertex Pharmaceuticals FAQ

How many employees does Vertex Pharmaceuticals have?

Vertex Pharmaceuticals has about 5,647 employees, up 1.5% over the 3 months to Jun 2025.

Does Vertex Pharmaceuticals sponsor H1B visas?

Yes. Vertex Pharmaceuticals filed 108 H1B (LCA) applications in FY2026, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.

What is Vertex Pharmaceuticals's revenue per employee?

Vertex Pharmaceuticals makes about $1.97M in revenue per employee, based on $11.1B annual revenue and 5,647 employees.

How much does Vertex Pharmaceuticals pay?

6figr has 38 salary profiles for Vertex Pharmaceuticals in the US, with pay broken down by role, level, gender and ethnicity on the Vertex Pharmaceuticals salaries page. See Vertex Pharmaceuticals salaries

Is Vertex Pharmaceuticals a public company?

Yes. Vertex Pharmaceuticals is publicly traded under the ticker VRTX on NASDAQ.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.